Table 1.
Study | Year | Study location | Treatments
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Treatment 1 | Age (years) | Cases/n | Treatment 2 | Age (years) | Cases/n | Treatment 3 | Age (years) | Cases/n | |||
| |||||||||||
Andersen et al7 | 1989 | France | Fluconazole | 32.1 | 143/169 | Clotrimazole | 30.6 | 131/161 | |||
Corić et al8 | 2006 | Croatia | Fluconazole | NA | 41/56 | Clotrimazole | NA | 9/13 | |||
Costa et al9 | 2004 | Brazil | Fluconazole | NA | 30/38 | Itraconazole | NA | 27/42 | |||
de Punzio et al10 | 2003 | Italy | Fluconazole | >18.0 | 29/38 | Itraconazole | >18.0 | 21/32 | |||
Fan et al11 | 2015 | China | Fluconazole | 19.0–45.0 | 241/287 | Miconazole | 19.0–45.0 | 220/290 | |||
Ferahbas et al12 | 2006 | Turkey | Fluconazole | 17.0–54.0 | 10/15 | Itraconazole | 17.0–54.0 | 6/10 | Terbinafine | 17.0–54.0 | 4/12 |
Li et al13 | 2015 | China | Fluconazole | 29.6 | 46/58 | Terconazole | 31.0 | 47/66 | |||
McClelland et al14 | 2015 | USA | Miconazole | 24.0–34.0 | 75/118 | Placebo | 23.0–35.0 | 30/116 | |||
Mendling et al15 | 2004 | Germany | Fluconazole | NA | 129/161 | Clotrimazole | NA | 117/154 | |||
Mikamo et al16 | 1995 | Japan | Fluconazole | 18.0–54.0 | 38/50 | Clotrimazole | 18.0–54.0 | 30/50 | |||
Mikamo et al5 | 1998 | Japan | Fluconazole | 18.0–55.0 | 40/50 | Itraconazole | 17.0–55.0 | 42/50 | Clotrimazole | 21.0–54.0 | 36/50 |
O-Prasertsawat and Bourlert17 | 1995 | China | Fluconazole | 33.9±8.1 | 42/53 | Clotrimazole | 35.3±8.4 | 40/50 | |||
Osser et al18 | 1991 | Sweden | Fluconazole | 16.0–52.0 | 100/121 | Econazole | 18.0–60.0 | 84/114 | |||
Seidman and Skokos19 | 2005 | USA | Fluconazole | 37.0±12.2 | 76/93 | Butoconazole | 38.8±13.8 | 56/88 | |||
Sekhavat et al20 | 2011 | Iran | Fluconazole | 39.4±13.1 | 60/72 | Clotrimazole | 42.2±15.9 | 49/70 | |||
Sobel et al21 | 1995 | USA | Fluconazole | 18.0–63.0 | 133/182 | Clotrimazole | 17.0–64.0 | 118/176 | |||
Sobel et al22 | 2004 | USA | Fluconazole | NA | 160/166 | Placebo | NA | 23/154 | |||
Stein et al23 | 1991 | USA | Fluconazole | 18.0–51.0 | 80/90 | Clotrimazole | 18.0–60.0 | 88/95 | |||
Stein and Mummaw24 | 1993 | USA | Itraconazole | 18.0–43.0 | 35/48 | Clotrimazole | 18.0–33.0 | 19/20 | Placebo | 18.0–39.0 | 7/22 |
Timonen25 | 1992 | Finland | Fluconazole | >18.0 | 50/54 | Miconazole | >18.0 | 33/47 | |||
Tobin et al26 | 1992 | UK | Itraconazole | >18.0 | 60/92 | Clotrimazole | >18.0 | 49/88 | |||
van Heusden et al27 | 1990 | Netherlands | Fluconazole | NA | 47/49 | Miconazole | NA | 48/50 | |||
Zhou et al28 | 2016 | China | Fluconazole | 29.9±6.5 | 61/110 | Clotrimazole | 29.4±6.2 | 62/115 | |||
Sobel et al42 | 1994 | USA | Ketoconazole | >18.0 | 86/101 | Clotrimazole | >18.0 | 41/51 | |||
Fong29 | 1992 | Canada | Itraconazole | 18.0–65.0 | 17/22 | Clotrimazole | 18.0–65.0 | 21/22 | |||
Gerhard et al43 | 1989 | USA | Ketoconazole | >18.0 | 27/45 | Placebo | >18.0 | 21/47 | |||
Kutzer et al46 | 1988 | UK | Fluconazole | 17.0–65.0 | 63/80 | Ketoconazole | 17.0–72.0 | 55/72 | |||
Sobel44 | 1986 | USA | Ketoconazole | 31.9 | 15/21 | Placebo | 31.9 | 6/21 | |||
van der Meijden et al45 | 1986 | Netherlands | Ketoconazole | 29.0±6.9 | 20/23 | Miconazole | 28.0±7.4 | 18/19 | |||
Kjaeldgaard58 | 1986 | USA | Terconazole | >18.0 | 18/20 | Clotrimazole | >18.0 | 17/20 | |||
Puolakka and Tuimala30 | 1983 | Finland | Ketoconazole | 16.0–46.0 | 40/49 | Miconazole | 18.0–47.0 | 34/49 | |||
Corson et al31 | 1991 | USA | Terconazole | 18.0–54.0 | 250/299 | Miconazole | 18.0–54.0 | 239/294 | |||
Thomason et al32 | 1990 | USA | Terconazole | NA | 40/50 | Miconazole | NA | 34/50 | Placebo | NA | 7/49 |
Brown et al39 | 1999 | USA | Butoconazole | 18.0–65.0 | 93/101 | Miconazole | 18.0–65.0 | 90/104 | |||
Ruf and Vitse40 | 1990 | France | Butoconazole | 18.0–56.0 | 26/29 | Econazole | 16.0–49.0 | 24/32 | |||
Kaufman et al37 | 1989 | USA | Butoconazole | >18.0 | 101/115 | Miconazole | >18.0 | 93/114 | |||
Hajman38 | 1988 | Sweden | Butoconazole | 20.0–63.0 | 28/32 | Clotrimazole | 19.0–32.0 | 24/31 | |||
Brown et al33 | 1986 | USA | Butoconazole | >18.0 | 26/32 | Miconazole | >18.0 | 21/30 | Placebo | >18.0 | 2/29 |
Adamson et al34 | 1986 | USA | Butoconazole | NA | 92/97 | Clotrimazole | NA | 74/88 | |||
Stettendorf et al35 | 1982 | USA | Clotrimazole | 16.0–62.0 | 45/54 | Econazole | 16.0–66.0 | 41/57 | |||
Perera and Seneviratne36 | 1994 | Sri Lanka | Econazole | NA | 49/51 | Clotrimazole | NA | 45/50 |